Lives shattered: Telangana factory blast leaves trail of grief in Odisha
2
3
4
Balasore/Kendrapada: In the quiet village of Erabanka in Jajpur district, Sanjukta Sahu sits motionless, tears streaming down her face. Her son, 30-year-old Dolagobinda, will never return home from his job at Sigachi pharmaceutical factory in Telangana.
"We are facing an uphill task after my son's death," she manages to say, her voice barely a whisper.
The devastating explosion that rocked the Pashamylaram industrial area has left multiple families across different states grappling with unbearable loss. Among them is the family of Rajanala Jagan Mohan, a 55-year-old accounts officer from Chhatrapur, Ganjam, who had dedicated over two decades to the company. His son, R.
Sai Yashwanth, recalls the horror of finding only his father's charred remains at the blast site.
Another heart-wrenching story is that of 47-year-old Manoj Rout from Balasore, who had just returned home on leave but was urgently called back to duty. His family could only identify his body through a ring on his finger. His wife now faces the daunting task of raising their two young sons, aged five and ten, alone.
The tragedy has also claimed the life of 20-year-old Lagnajeet Duari from Cuttack's Tigiria area, who had taken up the job to support his family.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
People Aged 50-85 With No Life Insurance Could Get This
Reassured
Get Quote
Undo
"We had dreams for him, but everything is shattered now," says his father, Manas Duari, fighting back tears.
Meanwhile, 24-year-old Samir Padhy from Baharapur fights for his life in a Hyderabad hospital's ICU with 35% burn injuries. His brother-in-law, Papu Kumar Choudhury, who witnessed the explosion, describes the terrifying sequence of events. "Thick smoke engulfed the area within minutes, trapping several workers inside," he said.
Nineteen-year-old Neelambar Batra from Nabarangpur district who narrowly escaped death, described the horrifying moments when the blast ripped through the pharmaceutical ingredient manufacturing plant. "I had just started my shift at the powder-making unit when a massive explosion shook the plant. Within seconds, everything around me was blown apart," he recalled, his voice trembling as he spoke from his hospital bed over phone.
The young worker, who hails from Bualiguda village under Jharigaon block, had migrated to Telangana just three months ago with four others, lured by the promise of Rs 700 per day for 12-hour shifts. "I feel lucky to have escaped with facial injuries, but I just want to return home and never work here again," said Batra, who is slowly recovering. Another youth from Batra's village, Chitrasen Bhadra, is currently undergoing treatment at Druva Hospital, Patancheru.
As families perform last rites and communities mourn their losses, questions about industrial safety standards and workers' protection loom large. The tragedy has not only claimed lives but has also left behind grieving families, truncated dreams, and communities struggling to come to terms with their devastating losses.
The Telangana government has provided initial compensation of Rs 1 lakh to affected families, but for many, like Sarbani, Dolagobinda's 24-year-old sister who remains in shock and unable to speak, no amount of money can fill the void left by their loved ones.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Biocon biologics receives European Commission approval for Vevzuo, Evfraxy Denosumab biosimilars for bone diseases
Biocon Ltd on Thursday said its arm Biocon Biologics Ltd has been granted marketing authorisation by the European Commission for Vevzuo and Evfraxy biosimilars of Denosumab used in the treatment of different bone diseases. The marketing authorisation for the European Union (EU) follows a positive opinion issued by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on April 25, 2025, Biocon Ltd said in a regulatory filing. Vevzuo is authorised for the prevention of bone complications in adults with advanced cancer involving bone and the treatment of adults and skeletally mature adolescents with giant cell tumour (GCT) of bone. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now Evfraxy is authorised for the treatment of osteoporosis in men and postmenopausal women, the treatment of bone loss linked to hormone ablation in men with prostate cancer at increased risk of fractures or the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adults, the company said. "The approval of Vevzuo and Evfraxy in Europe underscores our strong scientific expertise and commitment to expanding patient access to essential medicines, including to new therapeutic areas such as bone health," Biocon Biologics CEO & Managing Director Shreehas Tambe said. Live Events Further, Tambe said, "In the past 18 months, we have successfully secured regulatory approvals for three biosimilars in Europe and two in the UK. These Denosumab biosimilars mark another significant milestone in our rapid expansion and support for healthcare systems in the region."
Time of India
an hour ago
- Time of India
'Scientific evidence refutes that Covid vaccines are responsible for sudden deaths': Medical expert
Speaking to ANI, Dr Mohit Gupta, Professor of Cardiology, GB Pant Hospital, said that findings from a study conducted on 1,600 heart attack patients showed a protective benefit of the Covid-19 vaccines. NEW DELHI: Medical experts have rejected allegations that Covid-19 vaccines are responsible for a recent spike in heart attack-related deaths, following comments made by Karnataka Chief Minister Siddaramaiah regarding over twenty such deaths in Hassan district. Speaking to ANI, Dr Mohit Gupta, Professor of Cardiology, GB Pant Hospital, said that findings from a study conducted on 1,600 heart attack patients showed a protective benefit of the Covid-19 vaccines. He said, "In our own study on 1,600 patients with heart attacks who had received the Covid vaccine and those who had not received it. We found that those who have received the Covid vaccine not only have lower chances of having a heart attack, all-cause mortality and sudden deaths, but also, following them for 30 days and 6 months, the chances of death of those people are significantly reduced." "The Covid-19 vaccine is harmless and also plays a protective role. This study is not only ours; ICMR has also validated this. Multiple hospitals have conducted big studies on this. A Korean study on around 2 lakh people replicated the same results. The US Covid Collaboration replicated similar results. In our study, we took both the Covid vaccines and similar results were shown for both the Covaxin and Covishield," he added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo Refuting any linkage between cardiac deaths and Covid vaccines, Dr Gupta said that scientific evidence refutes that Covid vaccines are responsible for sudden deaths. The doctor stated, "This is a sudden hype. If we see practically too, then we have given this vaccine all over the country, so if that is the case, there will be clustering, multiple deaths will be reported from different parts of the country, which will be significantly increased, but in the last 5 years, nothing such has happened. Suddenly, if there are 4-5 cases and if we think that is because of the vaccine, then no. there are multiple reasons of sudden cardiac death. .. I think we really has to be think over... Scientific evidence refutes that Covid vaccines are responsible for sudden deaths..." Earlier, Kiran Mazumdar Shaw, the Executive Chairperson of Biocon Limited echoed similar sentiments and refuted the allegation of the Karnataka Chief Minister Siddaramaiah, in which he attributed more than twenty deaths due to heart attacks in the past one month in district of Hassan to Covid vaccines. She said that it was factually incorrect to suggest that Covid vaccines were hastily approved. Earlier in a post on X, CM Siddaramaiah shared that in the past month, in just one district of Hassan, more than twenty people died due to heart attacks. CM Siddaramaiah said, "In the past month alone, in just one district of Hassan, more than twenty people have died due to heart attacks. The government is taking this matter very seriously. To identify the exact cause of these series of deaths and to find solutions, a committee of experts has been formed under the leadership of Dr. Ravindranath, Director of Jayadeva Institute of Cardiovascular Sciences and Research, and they have been instructed to submit a study report within 10 days. " He further said that orders were given to this same committee back in February to conduct a thorough study on the reasons behind sudden deaths among young people in the state, and whether the Covid vaccines could have any adverse effects. In this regard, the process of examining and analysing heart patients is also underway. On July 2, a press release by the Union Health Ministry said that studies by the Indian Council of Medical Research (ICMR) and National Centre for Disease Control (NCDC) have established that there is no direct link between Covid-19 vaccination and the reports of sudden deaths in the country.
Indian Express
2 hours ago
- Indian Express
Opposition alleges Maharashtra govt purchased cancer diagnostic vans at inflated price, Speaker Rahul Narvekar orders inquiry
Maharashtra Assembly Speaker Rahul Narvekar Thursday directed the public health department to conduct an inquiry into the purchase of eight cancer diagnostic vans and submit its findings before the end of the Monsoon Session after the Opposition's allegations. Opposition MLAs questioned the price at which each of the vans was purchased. 'As per the information I have, the price of each van was Rs 99 lakh, while a similar van of the Tata company can be purchased at Rs 45 lakh only. The entire purchase process looks managed and there can be no denying this,' said Shiv Sena (UBT) MLA Bhaskar Jadhav. Meghana Sakore-Bordikar, Minister of State for Public Health, stated that the purchase of eight cancer diagnostic vans was made through the government's GeM portal via a turnkey process. The rates at which purchases were made were 0.94 per cent less than the estimated rates. There was a competitive tender for the same. It involves the vehicle, medical equipment, furniture and customisation. There has been no corruption in the purchase,' said the minister. She said three companies had participated in the tender process. 'At present, an inquiry is ongoing based on complaints from the legislators,' she said. 'The government has purchased eight cancer diagnostic vans. The price of a van cannot exceed Rs 40 lakh. The equipment in this van is not more than Rs 12 lakhs. However, the vehicles have been purchased at a higher price,' said Congress MLA Vijay Wadettiwar. Wadettiwar said these vans are related to a life-threatening disease like cancer, and some of the equipment has even broken down. 'There should be an investigation into whether there has been corruption in this purchase. The report must come out if the investigation is ongoing,' he said. The Congress MLA asked the Speaker to ensure that the report is tabled before the house, before the end of the session. 'The inquiry must be conducted at the earliest and the report should be tabled before the House before the end of the session,' said Speaker Narvekar.
